ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,124,549,707
- Total 13F shares
- 61,630,296
- Share change
- -3,644,161
- Total reported value
- $389,584,078
- Put/Call ratio
- 275%
- Price per share
- $6.32
- Number of holders
- 188
- Value change
- -$21,451,973
- Number of buys
- 101
- Number of sells
- 67
Quarterly Holders Quick Answers
What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45256X103:
Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
1.3%
|
14,184,277
|
$76,169,567 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
13,539,590
|
$72,707,598 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.92%
|
10,375,311
|
$55,715,419 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
3,481,386
|
$18,697,626 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.14%
|
1,548,826
|
$8,317,196 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
1,435,746
|
$7,709,956 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
1,310,789
|
$7,038,937 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
1,310,390
|
$7,036,794 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.11%
|
1,267,142
|
$6,804,553 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
1,215,381
|
$6,526,596 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
1,171,212
|
$6,289,408 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
1,128,446
|
$6,059,755 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.09%
|
1,052,887
|
$5,654,003 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
1,036,789
|
$5,567,557 | — | 31 Mar 2024 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.08%
|
945,720
|
$5,078,516 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
925,489
|
$4,969,875 | — | 31 Mar 2024 | |
| ALLEN HOLDING INC /NY |
13F
|
Company |
0.06%
|
687,571
|
$3,692,256 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
624,601
|
$3,354,108 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
506,425
|
$2,719,502 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
450,794
|
$2,420,764 | — | 31 Mar 2024 | |
| Clearwater Capital Advisors, LLC |
13F
|
Company |
0.04%
|
443,299
|
$2,380,516 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.03%
|
391,752
|
$2,103,708 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
385,669
|
$2,071,041 | — | 31 Mar 2024 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.03%
|
335,709
|
$1,802,757 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.03%
|
313,542
|
$1,683,721 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
308,138
|
$1,654,701 | — | 31 Mar 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.02%
|
270,950
|
$1,455,002 | — | 31 Mar 2024 | |
| Sculptor Capital LP |
13F
|
Company |
0.02%
|
266,200
|
$1,429,494 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
263,100
|
$1,412,847 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.02%
|
236,634
|
$1,270,725 | — | 31 Mar 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.02%
|
221,530
|
$1,189,616 | — | 31 Mar 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
205,092
|
$1,119,000 | — | 31 Mar 2024 | |
| John C. Thomas |
3/4/5
|
Former Director |
—
class O/S missing
|
216,363
|
$1,086,143 | — | 31 Dec 2021 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.02%
|
201,343
|
$1,081,212 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
186,875
|
$1,003,506 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.02%
|
182,930
|
$982,334 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
178,930
|
$960,854 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
160,391
|
$861,300 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.01%
|
153,000
|
$835,380 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
133,373
|
$716,213 | — | 31 Mar 2024 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
128,321
|
$689,084 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.01%
|
123,879
|
$667,000 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
115,146
|
$618,335 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
111,388
|
$598,154 | — | 31 Mar 2024 | |
| MERIDIAN INVESTMENT COUNSEL INC. |
13F
|
Company |
0.01%
|
96,433
|
$517,845 | — | 31 Mar 2024 | |
| Tidal Investments LLC |
13F
|
Company |
0.01%
|
92,839
|
$498,546 | — | 31 Mar 2024 | |
| Winning Points Advisors, LLC |
13F
|
Company |
0.01%
|
92,786
|
$465,786 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
55,311
|
$449,125 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
81,629
|
$438,348 | — | 31 Mar 2024 | |
| Merit Financial Group, LLC |
13F
|
Company |
0%
|
43,812
|
$400,880 | — | 31 Mar 2024 |
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2024
As of 30 Jun 2024,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,630,296 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, UBS ASSET MANAGEMENT AMERICAS LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, and GOLDMAN SACHS GROUP INC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
157
Q2 2024 holders
188
Holder diff
31
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.